Topics:

Arthritis

Five Reasons Your Patients Should Join Arthritis Power

A new symptom-tracking app isn't merely about helping your patients. It's about helping them help everyone with their condition by sharing their experience in a systematic way. Founder Jeffrey Curtis MD describes the new registry and its goals.

Arthritis

rheumatoid arthritis

In the second installment of a slide show based on an animated discussion by members of the rheumatology journal club (#rheumjc), partipants focus on the benefits, risks, and realities of tapering biologics in clinical practice.

rheumatoid arthritis

Slides present key points from a Twitter-based journal club, pondering a randomized study of tapering TNF inhibitors in rheumatoid arthritis. Many questions about the study design. More ask about practices already in use (addressed in Part 2).

The biologic adalimumab improves pain and physical function in a randomized trial of patients with peripheral spondyloarthritis unable to take non-steroidal anti-inflammatory drugs.

Two studies suggest that prolonged morning stiffness is linked with disease course in rheumatoid arthritis. Should it be added to criteria sets?

(OARSI2015) Osteoarthritis specialists hope researchers will help them unite individual patient data from different trials to conquer difficult questions about the disease.

Bone erosions found at a rheumatoid arthritis (RA) patient’s baseline exam are harbingers of future joint damage and more severe disease. As to why this is so, new studies offer only hints.

(OARSI2015) Researchers can now describe how osteoarthritis patients may become sensitized to feel pain beyond the affected joint. Different brain areas are triggered than in fibromyalgia, and biochemical studies offer clues to new kinds of pain relief.

Pages

Subscribe to Arthritis on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.